Cite
HARVARD Citation
Komatsu‐Fujii, T. et al. (2019). Response to imatinib in vaginal melanoma with KIT p.Val559Gly mutation previously treated with nivolumab, pembrolizumab and ipilimumab. Journal of dermatology. 46 (6), pp. e203-e204. [Online].